🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Visugromab in Cachexia International Trial

RecruitingPhase 2, Phase 3Ages 18 Years - anyAllCatalYm GmbH
NCT07112196 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A study of how well and safely a new drug called visugromab works in people with certain kinds of cancer (including lung and bowel cancer) and unintended weight loss known as cachexia. The main questions it aims to answer are: * Does visugromab help participants put weight back on and have a better appetite? * Does visugromab help participants move more and better? * What medical problems do participants have when taking visugromab? Researchers will compare visugromab to a placebo (a look-alike substance that contains no drug). Participants will visit the hospital or clinic once every 4 weeks to receive visugromab or placebo via a drip into a vein and to undergo checkups and tests.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Weight loss * Advanced cancer Exclusion Criteria: * Participation in another interventional clinical trial, receipt of any investigational therapy or use of any investigational device within 4 weeks prior to screening and between screening and the first dose of investigational product
💊

What it tests

  • Visugromab (CTL-002)
  • Placebo
  • Visugromab (CTL-002)
  • Visugromab (CTL-002)
📍

Where

74 sites
Eastern Connecticut Hematology & Oncology
Norwich, United States
Clermont Oncology Center
Clermont, United States
Mid Florida Hematology and Oncology Centers
Orange City, United States
Cleveland Clinic Martin Health
Stuart, United States
Augusta University Medical Center
Augusta, United States
Astera Cancer Care
East Brunswick, United States
Cleveland Clinic Avon Hospital
Avon, United States
Cleveland Clinic (Main Campus)
Cleveland, United States

…and 66 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy